Form 4: C3.ai Director Lisa Ann Davis Acquires Stock Options

Lisa Ann Davis, a director of C3.ai, acquired stock options for 23,642 shares on October 2, 2024, according to a Form 4 filing with the SEC.

Summary

• On October 2, 2024, Lisa Ann Davis, a director of C3.ai, acquired stock options for 23,642 shares of Class A Common Stock at an exercise price of $22.89.
• The options vest quarterly, with 5% of the shares vesting on the last day of each fiscal quarter, provided Ms. Davis attends the regularly scheduled board meeting.
• If Ms. Davis misses a board meeting, the vesting of those shares is suspended and may vest only after the fifth anniversary of the vesting commencement date if attendance requirements are met in subsequent periods.
• The options expire on October 1, 2034.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating a standard compensation practice. It doesn't contain overtly positive or negative information, hence a neutral sentiment score.

Positives

• The acquisition of stock options by a director signals confidence in the company's future performance.

Risks

• The vesting schedule is contingent upon Ms. Davis's continued service as a director and her attendance at board meetings; failure to meet these conditions could impact the vesting of the options.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule incentivizes continued service and engagement from the director.

Industry Context

This is a standard SEC filing related to stock option grants to a company director, a common practice in publicly traded companies to align the interests of management and shareholders.

Comparison to Industry Standards

• Stock option grants to directors are a common practice across the tech industry, used to incentivize performance and align interests with shareholders.
• Companies like Palantir, Snowflake, and Databricks also utilize stock options as part of their compensation packages for directors and executives.
• The vesting schedules and exercise prices are typically benchmarked against industry standards and company-specific performance metrics.

Key Dates